Showing results (1211-1220 of 16,132) with videos related to
Sort By:
Pageof 1,614
Drug Discovery Today|January 12, 2023
The myotonic dystrophy type 1 drug development pipeline: 2022 editionMarta Pascual-Gilabert, Ruben Artero, Arturo López-CastelJac-Antimicrobial Resistance|July 5, 2021
CON: Carbapenems are NOT necessary for all infections caused by ceftriaxone-resistant EnterobacteralesJesús Rodríguez-Baño, Belén Gutiérrez-Gutiérrez, Alvaro PascualPediatric Clinics of North America|June 1, 1987
Hemofiltration in children with renal failureJ F Pascual, J D López, M MolinaPlos Genetics|October 15, 2020
Correction: Ferritin heavy chain protects the developing wing from reactive oxygen species and ferroptosisSimone Mumbauer, Justine Pascual, Irina Kolotuev, et al.Sensors (Basel, Switzerland)|December 11, 2022
Robust Precoding for Multi-User Visible Light Communications with Quantized Channel InformationOlga Muñoz, Antonio Pascual-Iserte, Guillermo San ArranzJournal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 26, 2021
A Less Frequent Etiology of Limb Shaking Syndrome: A Severe Middle Cerebral Artery StenosisMikel Vicente-Pascual, Gerard Mauri-Capdevila, Francisco PurroyCurrent Medical Research and Opinion|August 6, 2019
Intravitreal dexamethasone implant Ozurdex in the treatment of diabetic macular edema in patients not previously treated with any intravitreal drug: a prospective 12-month follow-up studyMarc Menezo, Manuel Roca, Víctor Menezo, et al.Journal of Parkinson'S Disease|November 8, 2018
Conversion of L-dopa to Extended Release L-dopa (Rytary®) in Patients with Fluctuating Parkinson's Disease: Predictors of DoseWilliam Ondo, Pablo Coss, Melissa Christie, et al.BMC Pregnancy and Childbirth|July 26, 2019
Consensus on priorities in maternal education: results of Delphi and nominal group technique approachesCarmen Paz-Pascual, Isabel Artieta-Pinedo, Gonzalo Grandes, et al.Diagnostic Microbiology and Infectious Disease|March 15, 2008
Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum beta-lactamases or plasmid-mediated AmpC-type beta-lactamasesM Carmen Conejo, J Ramón Hernández, Alvaro PascualPageof 1,614